Beckman Coulter Life Sciences Acquires Flow Cytometry Firms Xitogen, Cytojene | GenomeWeb

NEW YORK (GenomeWeb) – Beckman Coulter Life Sciences today announced it is acquiring Chinese flow cytometry firms Xitogen Technologies and Cytojene for an undisclosed amount.

Based in Suzhou and Dalian, China, Xitogen provides Beckman Coulter an operational base in China and "a high quality research instrument" that rounds out Beckman Coulter's cytometry portfolio, the Danaher business said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.